Primary Outcomes from a Randomized, Phase III Study of Belatacept vs Cyclosporine in Kidney Transplant Recipients (BENEFIT Study)

dc.contributor.authorVincenti, Flavio
dc.contributor.authorGrinyo, Josep M.
dc.contributor.authorCharpentier, Bernard
dc.contributor.authorPestana, Jose Osmar Medina [UNIFESP]
dc.contributor.authorRostaing, Lionel
dc.contributor.authorVanrenterghem, Yves
dc.contributor.authorDi Russo, Gregory B.
dc.contributor.authorGarg, Pushkal
dc.contributor.authorLin, Chen-Sheng
dc.contributor.authorLarsen, Christian
dc.contributor.institutionUniv Calif San Francisco
dc.contributor.institutionUniv Hosp Bellvitge
dc.contributor.institutionHop Bicetre
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionCHU Rangueil
dc.contributor.institutionUniv Hosp Kuleuven
dc.contributor.institutionBristol Myers Squibb Co
dc.contributor.institutionEmory Univ
dc.date.accessioned2018-06-18T12:15:05Z
dc.date.available2018-06-18T12:15:05Z
dc.date.issued2009-08-01
dc.description.affiliationUniv Calif San Francisco, Transplant Ctr, San Francisco, CA 94143 USA
dc.description.affiliationUniv Hosp Bellvitge, Div Nephrol, Barcelona, Spain
dc.description.affiliationHop Bicetre, Dept Nephrol, Le Kremlin Bicetre, France
dc.description.affiliationHosp Rim & Hipertensao Unifesp, Div Nephrol, Sao Paulo, Brazil
dc.description.affiliationCHU Rangueil, Nephrol Dialysis & Multiorgan Transplant Unit, F-31054 Toulouse, France
dc.description.affiliationUniv Hosp Kuleuven, Dept Nephrol, Louvain, Belgium
dc.description.affiliationBristol Myers Squibb Co, Immunol, Princeton, NJ USA
dc.description.affiliationEmory Univ, Sch Med, Emory Transplant Ctr, Atlanta, GA USA
dc.description.affiliationUnifespHosp Rim & Hipertensao Unifesp, Div Nephrol, Sao Paulo, Brazil
dc.description.sourceWeb of Science
dc.format.extent89-89
dc.identifierhttp://dx.doi.org/10.1111/j.1432-2277.2009.00961.x
dc.identifier.citationTransplant International. Malden: Wiley-blackwell Publishing, Inc, v. 22, (Suppl s2), p. 89-89, O-331, 2009.
dc.identifier.doi10.1111/j.1432-2277.2009.00961.x
dc.identifier.issn0934-0874
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/45681
dc.identifier.wosWOS:000269392800329
dc.language.isoeng
dc.publisherWiley-Blackwell
dc.relation.ispartofTransplant International
dc.rightsAcesso aberto
dc.rights.licensehttp://olabout.wiley.com/WileyCDA/Section/id-406071.html
dc.titlePrimary Outcomes from a Randomized, Phase III Study of Belatacept vs Cyclosporine in Kidney Transplant Recipients (BENEFIT Study)en
dc.typeResumo
Arquivos